Multidisciplinary approach to selective sentinel lymph node mapping in breast cancer

Breast Cancer

Volumn 7, Issue 2, 2000, Pages 105-113

  Leong, Stanley P L ^a   Morita, Engene T ^a   Treseler, Patrick A ^a   Wong, Jan H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Breast cancer; Sentinel lymph node mapping

Indexed keywords

BREAST TUMOR; FEMALE; HUMAN; METHODOLOGY; PATHOLOGY; PATIENT CARE; REVIEW; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; CONTINUITY OF PATIENT CARE; FEMALE; HUMANS; SENTINEL LYMPH NODE BIOPSY;

EID: 0034566429     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967441     Document Type: Review

References (83)

1. Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 39:456-466, 1977. (Pubitemid 8063506)
2. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992.
3. Reintgen DS, Cruse CW, Wells K: The orderly progression of melanoma nodal metastases. Anna Surg 220:759-767, 1994. (Pubitemid 24376374)
4. Ross MI, Reintgen DS, Balch C: Selective lymphadenectomy; Emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin in Surg Oncol 9:219-223, 1993. (Pubitemid 23154458)
5. Krag DN, Meijer SJ, Weaver DL, et al: Minimal-access surgery for staging of malignant melanoma. Arch Surg 130:654-658, 1995.
6. Thompson JF, McCarthy WH, Bosch CM, et al: Sentinel lymph node status as an indicator of the presence of metastatic melanonma in regional lymph nodes. Melanoma Research 5:255-260, 1995.
7. Leong SPL, Steinmetz I, Habib FA, et al: Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 132:666-673, 1997. (Pubitemid 27255614)
8. Reintgen DS: Changing standards of surgical care for melanoma patients. Ann Surg Oncol 3:327-328, 1996.
9. Coit D, Wallack M, Balch C: Society of Surgical Oncology practice guidelines; Melanoma surgical practice guidelines. Oncology 11:1317-1323, 1997.
10. Emilia JCD, Lawrence W: Sentinel lymph node biopsy in malignant melanoma; The standard of care? J Surg Oncol 65:153-154, 1997. (Pubitemid 27351700)
11. Houghton A, Coit D, Bloomer W, et al: NCCN melanoma practice guidelines. National Comprehensive Cancer Network. Oncology 12:153-177, 1998.
12. Leong SPL: The Role of Sentinel Lymph Node in Human Solid Cancer, In: Devita, Hellman, Rosenberg, eds, PPO Updates, Vol 12, Lippincott-Raven, Philadelphia, 1998.
13. Bland KI: Enhancing the accuracy for predictors of axillary nodal metastasis in T1 carcinoma of the breast; Role of selective biopsy with lymphatic mapping. J Am Coll Surg 183:262-264, 1996.
14. Giuliano AE: Mapping a pathway for axillary staging; A personal perspective on the current status of sentinel lymph node dissection for breast cancer. Arch Surg 134:195-199, 1999.
15. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-398; discussion 398-401, 1994.
16. Turner RR, Ollila DW, Krasne DL, et al: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226:271-276, 1997.
17. Krag D, Weaver D, Ashikaga T, et al: The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 339:941-946, 1998. (Pubitemid 28455095)
18. Van Diest P, Torrenga H, Borgstein PJ, et al: Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 35:14-18, 1999. (Pubitemid 29325292)
19. Veronesi U, Paganelli G, Galimberti V, et al: Sentinelnode biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864-1867, 1997. (Pubitemid 27270119)
20. Dowlatshahi K, Fan M, Snider HC, et al: Lymph node micrometastases from breast carcinoma; Reviewing the dilemma. Cancer 80:1188-1197, 1997 (Pubitemid 27407219)
21. Goldhirsch A, Castiglione M: Prognostic importance of occult axillary ltmph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group, Lancet 335:1565-1568, 1990. (Pubitemid 20189634)
22. Cote R, Peterson HF, Chaiwun B, et al: Role of immunohistochemical detection of lymph node metastases in management of breast cancer. International Breast Cancer Study Group, pp896-900, 1999.
23. Kelley S, Komorowski RA, Dayer AM: Axillary sentinel lymph node examination in breast carcinoma. Arch Pathol Lab Med 123:533-535, 1999. (Pubitemid 29255033)
24. Giuliano AE, Jones RC, Brennan M, et al: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345-2350, 1997. (Pubitemid 27251137)
25. Schreiber R, Pendas S, Ku NN, et al: Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol 6:95-101, 1999. (Pubitemid 29077494)
26. Pendas S, Dauway E, Cox CE, et al: Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 65:505-506, 1999.
27. Czerniecki B, Scheff AM, Callans LS, et al: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 85:1098-1103, 1999. (Pubitemid 29115589)
28. McIntosh S, Going JJ, Soukop M, et al: Therapuefic implications of the sentinel lymph node in breast cancer [letter]. Lancet 354:570, 1999. (Pubitemid 29381379)
29. Ku N: Pathological examination of sentinel lymph nodes in breast cancer. Surg Oncol Clin N Am 8:469-479, 1999. (Pubitemid 29321216)
30. Banks E, Jansen JF, Oberle E, et al: Cytokeratin posifivity in fine-needle aspirates of melanomas and sarcomas. Diagn Cytopathol 12:230-233, 1995.
31. Frisman D, Taylor CR: Immunohistologyof the skin; Melanoma, intermediate filament. Immunomicroscopy, Taylor CR, Cote RJ eds, A Diagnostic Tool for the Surgical Pathologist, 19, pp318-341, 1994.
32. Viale G, Bosari S, Mazzarol G, et al: Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 85:2433-2438, 1999. (Pubitemid 29244852)
33. Cserni G: Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol 52:922-924, 1999. (Pubitemid 30005368)
34. Turner R, Ollila DW, Stern S, et al: Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 23:263-267, 1999 (Pubitemid 29117560)
35. CibuU M: Handling sentinel lymph node biopsy specimens; A work in progress. Arch Pathol Lab Med 123:620-621, 1999.
36. Chu KU, Turner RR, Hansen NM, et al: Do all patiets with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229:536-541, 1999. (Pubitemid 30191752)
37. Schoenfeld A, Luqmani Y, Smith D, et al: Detection of breast cancer micrometastases in axillary lymph nodes by using polymerse chain reaction. Cancer Res 54:2986-2990, 1994. (Pubitemid 24187784)
38. Carter B, Jensen RA, Simpson JF, et al: Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 113:259-265, 2000. (Pubitemid 30212557)
39. Miner TJ, Shriver CD, Flicek PR, et al: Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph node [see comments]. Ann Surg Oncol 6:75-82, 1999. (Pubitemid 29077491)
40. Glass E, Essner R, Morton DL: Kinetics of three lymphocintigraphic agents in patients with cutaneous melanoma. J Nucl Med 39:1185-1190, 1998. (Pubitemid 28326148)
41. Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet 349:1668-1669, 1997. (Pubitemid 27234813)
42. Giuliano AE: Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 350:958, 1997. (Pubitemid 27420545)
43. Haagensen CD, Feind CR, Herter FP, et al: The Lymphatics in Cancer, WB Saunders Company, Philadelphia, 1972.
44. Grant RN, Tabah EJ, Adair FE: The surgical significance of the subareolar plexus in cancer of the breast. Surgery 33:71-78, 1959.
45. Turner-Warwick RT: The lymphatics of the breast. Br J Surg 46:574-582, 1953.
46. Sappey MPC: Anatomie, Physiologie, Pathologie des Vaisseaux Lymphafiques Consideres chez I'homme et les Vertebres, DeLahaye A, Lecrosnier, Paris, 1874.
47. Rouviere H: Anatomie des Lymphatiques de l'Homme, Masson, Paris, 1932.
48. Linehan DC, Hill AD, Tran KN, et al: Sentinel lymph node biopsy in breast cancer; Unfiltered radioisotope is superior to filtered. J Am Coll Surg 188:377-381, 1999 (Pubitemid 29162695)
49. Klimberg VS, Rubio IT, Henry R, et al: Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 229:860-864, discussion 864-865, 1999.
50. Roumen RM, Geuskens LM, Valkenburg JG: In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol 25:347-51, 1999. (Pubitemid 29364218)
51. Vendrell-Torne E, Setoain-Quinquer, Domenech-Torne FM: Study of Normal Mammary Lymphatic Drainage Using Radiotracer Isotopes. J Nucl Med 13:801-805, 1972.
52. Harlow SP, Krag DN, Weaver DL, et al: Extra-axillary sentinel lymph nodes in breast cancer. Breast Cancer 6:159-165, 1999.
53. Leong SPL, Nwakanma L, Achtem TA, et al: Evolving Techniques in the Identification and Harvesting of Breast Cancer Sentinel Lymph Nodes. 2000 (Submitted for Publication).
54. Cady B: Lymph node metastases; Indicators, but not governors of survival. Arch Surg 119:1067-1072, 1984. (Pubitemid 14037331)
55. Nemoto T, Vana J, Bedwani RN, et al: Management and survival of female breast cancer; Results of a national survery by the American College of Surgeons. Cancer 45:2917-2924, 1980. (Pubitemid 11191732)
56. Carter C, Alan, C, Henson, DE: Relation of tumor size, lymph node status, and survival in 24 740 breast cancer cases. Cancer 63:181-187, 1989. (Pubitemid 19032001)
57. Fisher B, Wolmark N, Bauer M, et al: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Sur Gynecol Obstet 152:765-772, 1981. (Pubitemid 11072899)
58. NIHCC: Treatment of early breast cancer. JAMA 265:391-395, 1991.
59. Beahrs O, et al: Manual for Staging of Cancer, Lippincott 4th edition, 1992.
60. Ivens D, Hoe AL, Podd TJ, et al: Assessment of morbidity from complete axillary dissection. Br J Cancer 66:136-138, 1992.
61. Fisher B, Redmond C, Fisher ER, et al: Ten year results of randomized clinical trial comparing radical masectomy and total masectomy with or without radiation. NEJM 312:674-682, 1985.
62. CRCWP: Cancer Research Campaign Working Party; Cancer research campaign trial for early breast cancer. Lancet 11:55-60, 1980.
63. McArdle C, Crawford D, Dykes EH, et al: Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 73:264-266, 1986. (Pubitemid 16051040)
64. Fisher N, Redmond C, et al: Eight year results of a randomized clinical trial comparing total masectomy and lumpectomy with and without irradiation in the treatment of breast cancer. NEJM 320:822-828, 1989 (Pubitemid 19094701)
65. Rutqvist LE, Petterson D, Johansson H: Adjuvant radiation therapy versus surgery alone in operable breast cancer; Long-term follow-up in a randomized clinical trial. Radiother Oncol 26:104-110, 1993. (Pubitemid 23094675)
66. Hayward J: The surgeon's role in primary breast cancer. Breast Cancer Res Treat 1:27-32, 1981. (Pubitemid 12179411)
67. Langlands A, Prescott RJ, Hamilton T: A clinical trial in the management of operable breast cancer. Br J Surg 67:170-174, 1980. (Pubitemid 10173926)
68. Cabanes P, Salmon RJ, Vilcoq JR, et al: Value of axillary dissection in addition to lumpectomy and radiotherapy in early brest cancer. Lancet 329:1245-1248, 1992.
69. White R, Vezeridis MP, Konstadoulakis M, et al: Therapeutic options and results for the management of minimally invasive carcinoma of the breast; Influence of axillary dissection for treatment of T la and Tlb lesions.JACS 183:575-522, 1996
70. Overgaard M, Hansen PS, Solin LJ, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who recieve adjuvant chemotherapy. N J Eng Med 337:949-955, 1997 (Pubitemid 27425950)
71. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Eng J Med 337:956-962, 1997. (Pubitemid 27425951)
72. Krag D: The Sentinel Node for Staging Breast Cancer; Current Review. Breast Cancer 6:233-236, 1999.
73. Giuliano AE: See one, do twenty-five, teach one; The implementation of sentinel node dissection in breast cancer. Ann Surg Oncol 6:520-521, 1999. (Pubitemid 29428787)
74. Cox CE, Bass, Siddarth S, et al: Implementation of new surgical technology; Outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol 6:553-561, 1999. (Pubitemid 29428794)
75. Krag DN, Weaver DL, Alex JC, et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-340, 1993. (Pubitemid 24019852)
76. Pijpers R, Meijer S, Hoekstra OS, et al: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38:366-368, 1997. (Pubitemid 27376884)
77. Neiweg OE, Kapteijn BA, Peterse JL, et al: Identification of sentinel node in patients with breast carcinoma. Ned Tijdschr Geneeskd 140:2235-2239, 1996. (Pubitemid 26373404)
78. Schneebaum SSY, Cohen M, et al: Sentinel lymph node localization in breast cancer; A feasibility study. Presented SSO Meeting in Atlanta, GA, 1996.
79. Guenther JM, Krishnamoorthy M, Tan LR: Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 3:336-340, 1997.
80. Borgstein P, Pijpers R, Comans EF, et al: Sentinel lymph node biopsy in breast cancer: guidlines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275-283, 1998 (Pubitemid 28124433)
81. Barnwell J, Arrendonodo, MA, Kollmorgen D, et al: Sentinel lymph node biopsy in breast cancer. Ann Surg Oneol 5:126-130, 1998 (Pubitemid 29071281)
82. O'Hea BHA, El-Shirbiny AM, et al: Sentinel lymph node biopsy in breast cancer; Initial experience at Memorial Sloan-Kettering Cancer Institute. J Am Coll Surg 186:423-427, 1998. (Pubitemid 28169364)
83. Cox CE, Pendas S, Cox JM, et al: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645-651; discussion 651-653, 1998.